Skip to main content
Watch Insiders
Market intelligence
ANIKHealthcare

Anika Therapeutics Inc. insider activity

In the last 90 days, 2 corporate insiders purchased $223,200 of stock on the open market.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
1
90-day purchase value
$223,200
Corporate buyers
2
Latest transaction
May 1, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
May 1, 2026John B Henneman IiiDirectorOpen Market Purchase5,000$14.66$73,320
Apr 30, 2026Stephen D. GriffinPresident and CEOOpen Market Purchase12,200$12.29$149,881